不同時(shí)間窗內(nèi)rt-PA溶栓治療VBA腦梗死的效果及預(yù)后
[Abstract]:Objective to investigate the effect and prognosis of thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) in patients with vertebrobasilar artery (VBA) cerebral infarction. Methods Seventy-one patients with rt-PA cerebral infarction who received intravenous thrombolytic therapy in our hospital were divided into two groups according to the time of pathogenic-thrombolytic therapy. 35 patients within 3.0 hours were selected as the observation group. Another 36 patients who had been treated with thrombolytic therapy for 3. 0 h or 4. 5 h were used as control group. The effect and prognosis of thrombolytic therapy were compared between the two groups. Results there was no significant difference in NIHSS score and Barthel index between the two groups before thrombolytic therapy and at the 15th day after thrombolytic therapy (P0.05). The NIHSS score in the observation group was significantly lower than that in the control group only 90 days after treatment. The Barthel index was significantly higher than that of the control group (P0.05). After 7 days of thrombolytic therapy, the total effective rate was 82.86 in the observation group and 75.00 in the control group. There was no significant difference between the two groups after 7 days of thrombolytic therapy (蠂 2, 0.658, P < 0.418). The rate of intracerebral hemorrhage after thrombolytic therapy in the two groups was significantly lower than that in the control group (P0.05). There was no significant difference in mortality at 7 days after thrombolytic therapy between the two groups (P0.05). Conclusion the short-term effect of rt-PA thrombolytic therapy in patients with VBA cerebral infarction is similar to that in time window 3.0h 4.5h, and the risk of death is the same. However, 3.0h time window can reduce the incidence of ICH, and the long-term effect is remarkable.
【作者單位】: 承德醫(yī)學(xué)院附屬醫(yī)院神經(jīng)內(nèi)科;
【基金】:承德市科學(xué)技術(shù)局科技支撐計(jì)劃(201606A050)
【分類(lèi)號(hào)】:R743.33
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 張毓英;鄭國(guó)華;;現(xiàn)行急性缺血性腦血管病溶栓篩選標(biāo)準(zhǔn)的利與弊[J];臨床薈萃;2007年17期
2 杜鵬;朱清;趙東升;;急性缺血性腦卒中的溶栓治療[J];中國(guó)醫(yī)學(xué)文摘.內(nèi)科學(xué);1999年05期
3 張彬;孫曉江;;溶栓藥物的基礎(chǔ)和臨床研究的新進(jìn)展[J];中國(guó)臨床神經(jīng)科學(xué);2008年01期
4 姜軍松;;溶栓治療與顱內(nèi)出血[J];國(guó)外醫(yī)學(xué)(腦血管疾病分冊(cè));1993年03期
5 王芳芳;王金萍;;溶栓藥物的臨床研究新進(jìn)展[J];承德醫(yī)學(xué)院學(xué)報(bào);2011年03期
6 李富生;李用海;張自德;;溶栓藥物的臨床應(yīng)用[J];中原醫(yī)刊;1990年04期
7 何祥;急性缺血性腦卒中溶栓治療現(xiàn)狀[J];現(xiàn)代康復(fù);1999年11期
8 王伊龍;廖曉凌;董可輝;杜彬;趙性泉;高培毅;王擁軍;;溶栓相關(guān)臨床工具[J];中國(guó)卒中雜志;2006年06期
9 唐錦治;;溶栓藥物的臨床應(yīng)用[J];臨床內(nèi)科雜志;1986年04期
10 彭斌;;急性缺血性腦卒中溶栓治療進(jìn)展[J];內(nèi)科急危重癥雜志;2013年02期
相關(guān)會(huì)議論文 前2條
1 劉傳方;;腦梗死CT值測(cè)定溶栓時(shí)機(jī)研究[A];中華醫(yī)學(xué)會(huì)第七次全國(guó)神經(jīng)病學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2004年
2 張敏鳴;;多模式磁共振對(duì)急性缺血性腦卒中溶栓治療的評(píng)估進(jìn)展[A];2012年浙江省放射學(xué)術(shù)年會(huì)論文集[C];2012年
相關(guān)重要報(bào)紙文章 前5條
1 暨南大學(xué)附屬第一醫(yī)院 徐安定;卒中溶栓永無(wú)止境[N];健康報(bào);2013年
2 賈建平 王憲玲;哪些腦梗死需要溶栓[N];健康報(bào);2006年
3 徐明;溶栓別超過(guò)6小時(shí)[N];醫(yī)藥養(yǎng)生保健報(bào);2006年
4 重慶市第一人民醫(yī)院心內(nèi)科 楊石;腦梗死急性期溶栓治療,莫留遺憾[N];醫(yī)藥經(jīng)濟(jì)報(bào);2011年
5 陶錦琰;腦中風(fēng)的溶栓和康復(fù)新療法[N];健康報(bào);2000年
相關(guān)碩士學(xué)位論文 前6條
1 張小雪;超急性期缺血性腦卒中溶栓治療現(xiàn)狀及影響因素分析[D];內(nèi)蒙古科技大學(xué)包頭醫(yī)學(xué)院;2015年
2 時(shí)圣桂;GRASPS、SEDAN、HAT模型預(yù)測(cè)未溶栓治療的腦梗死出血轉(zhuǎn)化的臨床價(jià)值[D];青島大學(xué);2017年
3 蔡穎源;TGF-β1對(duì)腦梗死大鼠rt-PA溶栓后血腦屏障損傷的保護(hù)作用及其機(jī)制研究[D];南京醫(yī)科大學(xué);2013年
4 張碧月;影響rt-PA治療急性缺血性腦卒中患者臨床預(yù)后的因素分析[D];福建醫(yī)科大學(xué);2013年
5 晁猛;Hcy、UA與腦梗死腦白質(zhì)病變嚴(yán)重程度及認(rèn)知功能相關(guān)性研究[D];青島大學(xué);2017年
6 劉曉青;基底節(jié)區(qū)單發(fā)腦梗死的臨床、影像學(xué)特征及病因?qū)W研究[D];青島大學(xué);2017年
,本文編號(hào):2296765
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2296765.html